Figure 1: Expression profiles of the genes whose mRNA levels were significantly altered in the PBMCs of TA patients. The Agilent whole human genome DNA microarray was used for this analysis. (A, B) Line-graphs showing 15 (A) or 13 (B) genes whose expression were up-regulated (> 3.0-fold) or down-regulated (< 0.22- fold) in all eight TA patients compared with the healthy volunteers. The line for the FCN1 gene is highlighted in blue. The ordinate scale indicates relative log10 ratios. Up- or down-regulated genes are denoted by red lines and red font or green lines and green font, respectively. The blue line in (A) denotes the expression profile of the FCN1 gene (highlighted in a blue font).